GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

$28.26
-0.46 (-1.60%)
As of Sep 20, 10:17 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +70.7% upside
Low Target $34.28
Average Target $48.23
High Target $66.93
Current Price $28.26
Current
$28.26
Target
$48.23
$34.28 $48.23 avg $66.93
Scenario Analysis
Bear Case
$34.28
21.3%
Low target
Base Case
$48.23
+70.7%
Avg target
Bull Case
$66.93
+136.8%
High target
Risk/Reward
6.4x
Highly favorable
Price in Context
52-Week High
$31.44
-10.1% from high
52-Week Low
$12.04
+134.7% from low
Target vs 52W High
$48.23
+53.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%